NCT00413647View on ClinicalTrials.gov

A Phase I Study in Healthy Volunteers to Evaluate the Safety of CardioPET™ in Detection of Coronary Artery Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Coronary Artery Disease
Interventions
DRUG

CardioPET

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

Fluoropharma, Inc.
All Listed Sponsors
lead

Fluoropharma, Inc.

INDUSTRY